drugset / Trial / NCT01918657

Walnut Oral Immunotherapy for Tree Nut Allergy

NCT01918657 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this research study is to learn about the medical effects, safety, and how the Walnut Oral Immunotherapy (OIT) treatment affects your body (immune system). This type of immunotherapy involves giving increasing doses of walnut allergen to gradually build up a person's tolerance to walnut and at least one other tree nut. The goal of the study is to determine whether participants can tolerate (eat) walnuts and at least one other tree nut in their diet after stopping the study therapy.

Timeline

Start
2014-02
Primary completion
2016-02
Completion
2016-02

Outcome

Outcome not reported

Stopped: “Unable to get an IND from the FDA for the walnut powder”

Drugs

EvaluationDrugModalityDoseRoute
Comparator walnut powder Unknown 1500 mg —

Indications